10-20845280-T-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_006393.3(NEBL):c.1205A>C(p.Tyr402Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000523 in 1,586,598 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Y402Y) has been classified as Likely benign.
Frequency
Consequence
NM_006393.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006393.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NEBL | NM_006393.3 | MANE Select | c.1205A>C | p.Tyr402Ser | missense | Exon 12 of 28 | NP_006384.1 | ||
| NEBL | NM_001377322.1 | c.358-32340A>C | intron | N/A | NP_001364251.1 | ||||
| NEBL | NM_213569.2 | c.358-32340A>C | intron | N/A | NP_998734.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NEBL | ENST00000377122.9 | TSL:1 MANE Select | c.1205A>C | p.Tyr402Ser | missense | Exon 12 of 28 | ENSP00000366326.4 | ||
| NEBL | ENST00000417816.2 | TSL:1 | c.358-32340A>C | intron | N/A | ENSP00000393896.2 | |||
| NEBL | ENST00000482754.1 | TSL:5 | n.216A>C | non_coding_transcript_exon | Exon 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152136Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000798 AC: 20AN: 250750 AF XY: 0.0000516 show subpopulations
GnomAD4 exome AF: 0.0000544 AC: 78AN: 1434462Hom.: 0 Cov.: 28 AF XY: 0.0000433 AC XY: 31AN XY: 715296 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Tyr402Ser variant in NEBL has not been reported in the literature but has be en identified in a Caucasian infant with DCM tested by our laboratory (LMM unpub lished data). This variant has been identified in 1/8600 European American chrom osomes from a broad population by the NHLBI Exome Sequencing Project (http://evs .gs.washington.edu/EVS/). The affected amino acid is not well conserved in evolu tion, suggesting that this change may be tolerated. This is also supported by co mputational predictions (AlignGVGD, PolyPhen2, and SIFT), though this informatio n is not predictive enough to rule out pathogenicity. Additional information is needed to fully assess the clinical significance of the Tyr402Ser variant.
Primary dilated cardiomyopathy Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with serine, which is neutral and polar, at codon 402 of the NEBL protein (p.Tyr402Ser). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 45477). This variant has not been reported in the literature in individuals affected with NEBL-related conditions. This variant is present in population databases (rs375569591, gnomAD 0.01%).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at